GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Windlas Biotech Ltd

Windlas Biotech Board to consider equity share buyback proposal on April 17

BUYBACK ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 14 Apr 2026, 10:21 PM IST  ·  BSE ID: 26085a27-ba12-4fcd-aaf1-4322de1bda1c
View Original BSE Filing (PDF)
💡
In Simple Terms
Windlas Biotech's board will decide on April 17 whether to buy back its own shares from shareholders, following stock market rules.
🤖 AI Summary
  • Windlas Biotech Board scheduled for April 17, 2026 to consider equity share buyback proposal
  • Governed by SEBI Buy-Back Securities Regulations 2018 and Companies Act 2013 provisions
  • Trading window closure in effect from April 1, 2026 for all designated persons
  • Window remains closed until 48 hours after March 31, 2026 financial results disclosure
🏢 How This Affects the Company
💰
Financial Impact
Buyback will impact cash reserves and capital structure. Exact financial impact cannot be assessed until buyback details—size, price range, timeline—are approved and disclosed.
👥 What This Means For Shareholders
✅
Action Required
No immediate action required. Shareholders should await April 17 board outcome filing for buyback details and record date.
👤
Who Is Affected
All equity shareholders are potentially affected. Buyback terms—valuation, quantity, record date—will determine impact on per-share metrics.
🔍
Management Signal
Buyback indicates management intent to return capital and signal confidence in intrinsic value, pending regulatory approval.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
April 17 board outcome filing—check for buyback approval, quantity, price range, timeline disclosure
Financial results for year ended March 31, 2026—announced post-board meeting, trading window reopens 48 hours later
Buyback initiation notice under SEBI regulations—watch for commencement date and execution window announcement
MEDIUM RISK Buyback size and pricing mechanism unknown. Cash outlay impact on liquidity and debt ratios will depend on final parameters.
💡 Investor Takeaway
Windlas Biotech board meets April 17, 2026 to approve equity buyback. No buyback size, price, or timeline disclosed in notice. FY26 results disclosure triggers 48-hour trading window reopening. Details expected post-board decision.
⚖️ Strengths & Concerns

⚠️ Concerns

  • No buyback value, share quantity, or price range specified in board notice. Investors must await April 17 disclosure.
  • Trading window closure until post-results announcement creates temporary information asymmetry for designated insiders.
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.